*Registration payment includes Credit Cards and Interfund Transfers ONLY.
Pharmacists, Physicians, Physicians Assistants, Nurse Practitioners
Are you equipped with the tools to improve the care of patients with chronic pain? Pharmacists and other healthcare professionals are in an excellent position to assist with appropriate, patient-centered implementation of chronic pain guidelines. This knowledge-based CPE activity will equip pharmacists with the tools to effectively execute an opioid stewardship initiative in order to improve the care of patients with chronic pain as well as ensure guidelines are followed in a patient-centered manner.
Courtenay Wilson will present this program remotely. Onsite attendees will view the program from a screen in the AHEC Conference Room.
Webinar Information
Participants who are interested in taking this workshop as a webinar, please go to our webinar requirements page for more information and to test your computer and network your computer will be on prior to the class.
Continuing Education Credit For Pharmacists:
The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE# 0046-9999-19-056-L01-P (Pharmacist) provides 2.0 contact hours of continuing pharmacy education credit. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks. **No partial credit will be available**
For Physicians, Physician Assistants & Nurse Practioners:
The Carolinas HealthCare System/Charlotte AHEC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Carolinas HealthCare System/Charlotte AHEC designates this Live Activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty DO NOT intend to discuss an unlabeled, unapproved, or investigative use of a commercial product or device
